We want to reduce the
transmission of resistant bacteria
in neonatal intensive care units
across Europe and globally.

We want to reduce the
transmission of resistant bacteria

in neonatal intensive care units
across Europe and globally

Why this project

Nearly 1 in 10 newborns in Europe is admitted to a neonatal intensive care unit in the first days of life – that is around 400,000 admissions every year.

While care in a neonatal unit results in a greater chance of survival in newborns with serious illness, it also increases the risk of exposure to bacteria from the hospital environment. These can cause serious infections in babies, which are commonly resistant to many routinely used antibiotics.

The NeoIPC response

NeoIPC will identify best practices for the prevention of infections and surveillance of resistant bacteria in neonatal intensive care units in Europe. By conducting a clinical trial, the project will assess the safety and effectiveness of one or more specific, lowcost and simple interventions to prevent transmissions and infections with hospital bacteria in newborns.

Let’s work together to improve Infection Prevention and Control practices in neonatal care settings. 

We are setting up a collaborative learning environment, the NeoIPC Clinical Practice Network. Do you want to be part of it? Join by REGISTERING YOUR NICU. You will participate in a colonisation feasibility study and help us determine bacterial colonization levels across Europe and beyond. 

Get involved! Save lives

Governance

Led by the University of Padova, NeoIPC project consists of thirteen partners representing multiple institutions in Europe and Africa.